Spironolactone for Reducing Proteinuria in Diabetic Nephropathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00498537
Recruitment Status : Completed
First Posted : July 10, 2007
Last Update Posted : October 17, 2008
Information provided by:
VA Office of Research and Development